In this article, we take a look at the 5 biggest hospital companies in the world.
Keep Reading →
June 6 - News - Comments
Artisan Partners, a high value-added investment management firm, published its “Artisan Value Fund” fourth quarter 2021 investor letter – a copy of which can be downloaded...
Keep Reading →
March 1 - Hedge Fund Investor Letters, News - Comments
Artisan Partners, a high value-added investment management firm, published its ‘Artisan International Value Fund’ fourth quarter 2021 investor letter – a copy of which can...
Keep Reading →
February 24 - Hedge Fund Investor Letters, News - Comments
Artisan Partners, a high value-added investment management firm, published its ‘Artisan International Value Fund’ third quarter 2021 investor letter – a copy of which can...
Keep Reading →
November 25 - Hedge Fund Investor Letters, News - Comments
Artisan Partners, a high value-added investment management firm, published its ‘Artisan International Value Fund’ first quarter 2021 investor letter – a copy of which can...
Keep Reading →
May 18 - Hedge Fund Investor Letters, News - Comments
Fiduciary Management Inc., an investment management firm, published its “International Equity” first quarter 2021 investor letter – a copy of which can be downloaded here...
Keep Reading →
April 16 - Hedge Fund Investor Letters, News - Comments
In this article we will take a look at whether hedge funds think Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) is a good investment right now.
Keep Reading →
December 10 - Hedge Funds, News - Comments
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy...
Keep Reading →
July 6 - Hedge Funds, News - Comments
We hate to say this but, we told you so.
Keep Reading →
March 16 - Hedge Funds, News - Comments
Is Fresenius Medical Care AG & Co.
Keep Reading →
December 20 - Hedge Funds, News - Comments
Is Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of research.
Keep Reading →
October 10 - Hedge Funds, News - Comments
Hedge fund managers like David Einhorn, Bill Ackman, or Carl Icahn became billionaires through reaping large profits for their investors, which is why piggybacking their stock...
Keep Reading →
March 30 - Hedge Funds, News - Comments
Before we spend days researching a stock idea we'd like to take a look at how hedge funds and billionaire investors recently traded that stock.
Keep Reading →
December 17 - Hedge Funds, News - Comments
Out of hundreds of healthcare stocks that are trading on the U.S stock market, we have selected the top 75 healthcare dividend stocks to invest in.
Keep Reading →
July 17 - Dividend Stocks, News - Comments
We know that hedge funds generate strong risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy...
Keep Reading →
December 19 - Hedge Funds, News - Comments
One of his recent favorites is DaVita HealthCare Partners Inc (NYSE:DVA), which operates a network of dialysis treatment centers in the United States catering to patients that...
Keep Reading →
November 1 - Hedge Funds - Comments
In the midst of an aging population, the United States remains the market leader for medical devices, accounting for about one-third of the worldwide market.
Keep Reading →
September 20 - News - Comments
Shares of Rockwell Medical Inc (NASDAQ:RMTI) soared recently, after the dialysis treatment company announced positive results regarding a study of its iron replacement drug...
Keep Reading →
September 17 - News - Comments
In the medical technology industry, there is a clear divide between software and hardware.
Keep Reading →
September 9 - News - Comments
To the average investor, there are many indicators market participants can use to analyze their holdings. A duo of the best are hedge fund and insider trading activity.
Keep Reading →
September 3 - News - Comments
To the average investor, there are a multitude of indicators market participants can use to analyze their holdings.
Keep Reading →
August 26 - News - Comments
Obesity rates are soaring in the United States. According to the American Heart Association, 155 million adults and 24 million children are overweight or obese.
Keep Reading →
August 12 - News - Comments
Maybe Texas just needs to fire up Ol' Sparky again.
Keep Reading →
August 5 - News - Comments
Shares of the two largest kidney care companies in the United States, DaVita HealthCare Partners Inc (NYSE:DVA) and Fresenius Medical Care AG & Co.
Keep Reading →
July 12 - News - Comments
Shares of the two largest kidney care companies in the United States, DaVita HealthCare Partners Inc (NYSE:DVA) and Fresenius Medical Care AG & Co.
Keep Reading →
July 8 - News - Comments
Baxter International Inc. (NYSE:BAX), one of the fastest-growing healthcare multinational corporations of America, has a long history of strong financial credentials.
Keep Reading →
July 1 - News - Comments
Fresenius Medical Care AG & Co. (ADR) (NYSE:FMS) was in 6 hedge funds' portfolio at the end of the first quarter of 2013.
Keep Reading →
June 24 - News - Comments
Mednax Inc. (NYSE:MD) was in 14 hedge funds' portfolio at the end of March.
Keep Reading →
June 4 - News - Comments
According to most stock holders, hedge funds are seen as slow, outdated financial vehicles of yesteryear.
Keep Reading →
April 4 - News - Comments
Mednax Inc. (NYSE:MD) was in 14 hedge funds' portfolio at the end of the fourth quarter of 2012.
Keep Reading →
April 2 - News - Comments
Warren Buffett’s Berkshire Hathaway is now the largest shareholder of DaVita HealthCare Partners Inc (NYSE:DVA) with 13,607,935 shares as of December 31, 2012.
Keep Reading →
March 19 - Hedge Funds - Comments
The growing obesity epidemic is putting a strain on the U.S. health care system. But not everyone loses from this trend.
Keep Reading →
March 15 - News - Comments
In order to be successful in investing, just pick a great company and stick with it through ups and downs. That is what Charlie Munger often advises investors to do.
Keep Reading →
March 13 - News - Comments
At the end of last year, I proclaimed Omontys -- an erythropoiesis-stimulating agent, or ESA, that aids in the formation of red blood cells -- as one of my 10 drugs approved by...
Keep Reading →
February 25 - News - Comments
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis...
Keep Reading →
February 14 - News - Comments
Affymax, Inc. (NASDAQ:AFFY) received its first Food and Drug Administration approval last spring with Omontys for anemia in dialysis patients.
Keep Reading →
January 22 - News - Comments